| |
|
|
|
|
Aviron(AVIR)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
BancBoston
|
| |
|
|
Bear Stearns & Co. Inc.
|
| Status: |
|
|
Hambrecht & Quist
|
| |
| Address: |
297 North Bernardo Avenue
Mountain View,
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(415) 919-6500 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
3,000,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
12,285,990 |
| |
|
|
|
| Management: |
J. Leighton Read, M.D., Chairman/CEO
|
IPO Date: |
|
| |
Martin L. Bryant, M.D.,Ph.D., VP
|
|
|
| |
Victor Jegede, Ph.D., VP
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
manufactures, markets, develops, and discovers |
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
70 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Pasteur Merieux Connaught
|
S-1 Forms: |
|
| |
Glaxo
|
|
|
| |
SmithKline Beecham
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product/Services Portfolio |
 |
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1992
|
0.00 |
0.00 |
0.00 |
0.00 |
-753 |
0.00 |
| 1993
|
0.00 |
3947 |
-3947 |
0.00 |
-3772 |
-.56 |
| 1994
|
0.00 |
6709 |
-6709 |
0.00 |
-6502 |
-.73 |
| 1995
|
1707 |
13472 |
-11765 |
0.00 |
-11403 |
-1.24 |
| 1996
|
1625 |
19592 |
17967 |
0.00 |
-17501 |
-1.84 |
|
|
|
|
|
|
|
| |
|
| |
|
|
